Trade Summary

3 days ago, Dickinson Andrew D, serving as Chief Financial Officer at GILEAD SCIENCES, INC. (GILD), sold 3,000 shares at $125.40 per share, for a total transaction value of $376,200.00. Following this transaction, Dickinson Andrew D now holds 171,646 shares of GILD.

This sale represents a 1.72% decrease in Dickinson Andrew D's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, June 15, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 16, 2026 at 5:53 PM ET, 1 day after the trade was made.

GILEAD SCIENCES, INC. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - GENERAL industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.